The designation β4Q Tubulin Activators refers to a category of biochemical agents that interact with a specific form of tubulin, presumably the β4Q isoform. Tubulin is a globular protein that polymerizes to form microtubules, which are essential components of the cytoskeleton in eukaryotic cells. These structures play critical roles in a variety of cellular processes including cell shape maintenance, intracellular transport, and the segregation of chromosomes during cell division. The β4Q nomenclature suggests a particular beta-tubulin isoform that may have a glutamine (Q) at a specific position, which could confer unique properties compared to other beta-tubulin isoforms. Activators in this context would be molecules that bind to this isoform and promote its polymerization or stabilization of microtubules, or perhaps enhance its interaction with other microtubule-associated proteins. Identifying such activators would typically entail a deep understanding of the β4Q tubulin's structure, the polymerization dynamics of microtubules, and the protein-protein interactions that are critical for its function. Screening methods might include high-throughput chemical assays to identify compounds that affect the rate of tubulin polymerization or stabilization.
Once potential β4Q Tubulin Activators are identified, extensive research would be conducted to determine their mode of action. This could involve a combination of biophysical techniques to monitor microtubule assembly in real-time, such as total internal reflection fluorescence (TIRF) microscopy, or to observe the stabilizing effects of these activators on microtubule structure using cryo-electron microscopy. Further, understanding the binding interaction at an atomic level would likely require computational modeling and simulation, followed by empirical validation using methods such as X-ray crystallography or NMR spectroscopy. The focus of developing such activators would be to dissect the biological functions of β4Q tubulin within the cell and to ascertain its role in the complex network of cytoskeletal proteins. This knowledge could provide valuable insights into the fundamental cellular processes that govern cell shape, motility, and division. Moreover, β4Q Tubulin Activators could become indispensable tools in the study of microtubule dynamics, offering researchers a means to probe the structure and function of microtubules with unprecedented specificity and detail.
더보기
| 제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
파클리탁셀은 미세소관을 안정화시키고 미세소관 역학을 유지하기 위한 세포 반응으로 튜뷸린 발현의 보상적 상향 조절을 유도할 수 있습니다. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
노코다졸은 미세소관 중합을 방해하여 세포 반응을 일으켜 미세소관 기능을 회복하기 위해 튜불린 합성을 증가시킬 수 있습니다. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
콜히친은 튜불린에 결합하여 미세소관 중합을 억제합니다. 세포는 이러한 억제를 극복하기 위해 튜뷸린 발현을 증가시킬 수 있습니다. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
빈블라스틴은 미세소관 조립을 방해합니다. 세포는 보상 메커니즘으로 튜불린 유전자 발현을 상향 조절하여 반응할 수 있습니다. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
위타페린 A는 튜불린에 결합하여 그 역학에 영향을 미쳐 잠재적으로 튜불린 유전자 발현의 조절을 변화시킬 수 있는 것으로 알려져 있습니다. | ||||||
Epothilone A | 152044-53-6 | sc-207628 sc-207628A | 10 µg 1 mg | $210.00 $1000.00 | 1 | |
에포틸론 B는 미세소관 안정화제입니다. 파클리탁셀과 마찬가지로 피드백 반응으로 튜불린 발현의 상향 조절을 일으킬 수 있습니다. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
포도필로톡신은 튜불린 중합을 억제하여 세포가 미세소관 기능을 유지하기 위해 더 많은 튜불린을 생성하도록 자극할 수 있습니다. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
메토트렉세이트는 디하이드로폴레이트 환원효소를 억제하여 세포 증식에 영향을 미칩니다. 이는 세포 주기 조절의 일부인 튜불린 발현에 영향을 미칠 수 있습니다. | ||||||